Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
Carlo Visco(University of Verona), Ken H. Young(The University of Texas MD Anderson Cancer Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(NewYork–Presbyterian Hospital), Maurilio Ponzoni(San Raffaele University of Rome), S. Dirnhofer(University Hospital of Basel), Y. C. Tai, B. S. Kahl(UW Health University Hospital), W.-m. Liu, E. D. His(Cleveland Clinic), Ronald S. Go(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(The University of Texas MD Anderson Cancer Center), Qin Huang(City Of Hope National Medical Center), Emanuele S. G. d'Amore(Ospedale San Bortolo), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University Hospital of Basel), Weiyun Z. Ai(University of California, San Francisco), April Chiu(Memorial Sloan Kettering Cancer Center), Roberto N. Miranda, H.-Y. Wang(University of California San Diego), Y. Zu(Methodist Hospital), C. H. Dunphy(University of North Carolina at Chapel Hill), Miguel Á. Piris(Marqués de Valdecilla University Hospital), Santiago Montes‐Moreno(Marqués de Valdecilla University Hospital), Liyun Wu, S. O'Neill(University of North Carolina at Chapel Hill), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), W. W. Choi(University of Hong Kong), Yanping Li(Southwest University), L. Jeffrey Medeiros(The University of Texas MD Anderson Cancer Center), X. Frank Zhao(University of Maryland, Baltimore), Jane N. Winter(Northwestern University)
Cited by 165
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
|The Lancet|2021|1.1k